Research Focus

Former Employee. Medicine; Research Stdy Asst II

Recent additions – View all

1. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma

   Journal Article

   Galsky, M. D.; Mironov, S.; Iasonos, A.; Scattergood, J.; Boyle, M. G.; Bajorin, D. F.
   Investigational New Drugs (2007)

   Fulltext@MSK | Save
2. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract

   Journal Article

   Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Donat, S. M.; Bochner, B. H.; Herr, H. W.; Russo, P.; Boyle, M. G.; Bajorin, D. F.
   Urology (2007)

   Fulltext@MSK | Save
3. Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function

   Journal Article

   Galsky, M. D.; Iasonos, A.; Mironov, S.; Scattergood, J.; Boyle, M. G.; Bajorin, D. F.
   Cancer (2007)

   Fulltext@MSK | Save